Medicine News and Research

RSS

Study shows hospitals costs vary widely and are not associated with quality of care

The costs that hospitals incur in treating patients vary widely and do not appear to be strongly associated either with the quality of care patients receive or their risk of dying within 30 days, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Feb 2010

Cancer Institute awards MCRA designation to Cooper University Hospital

Enhancing its collective strength in the area of oncology research in the state, The Cancer Institute of New Jersey has announced that Cooper University Hospital will be the fourth affiliate hospital within its Network to receive the prestigious Major Clinical Research Affiliate designation.

23 Feb 2010

Senate, FDA reports increasing concerns about controversial diabetes drug

"Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market ... ," The New York Times reports. "The internal F.D.A. reports are part of a fierce debate within the agency over what to do about Avandia, manufactured by GlaxoSmithKline."

23 Feb 2010

DSAEK cornea transplant offers potential long-term benefits

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty experienced greater cell loss overall compared to those who underwent penetrating keratoplasty, according to a new analysis of data collected from the Cornea Donor Study Investigator Group's 2008 Specular Microscopy Ancillary Study.

23 Feb 2010

Gilead Sciences receives FDA approval for new inhaled antibiotic in treatment of CF

The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis. The drug was made possible by significant support from the Cystic Fibrosis Foundation, including a $1 million investment by a Foundation subsidiary to help develop the therapy.

22 Feb 2010

U.S. HealthWorks expands its footprint in Arizona by acquiring three healthcare centers

U.S. HealthWorks, a leading operator of occupational healthcare centers in the nation, today announced the acquisition of all three Tucson Occupational Medicine healthcare centers.

22 Feb 2010

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., with one person newly diagnosed every nine minutes.

22 Feb 2010

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a Phase IIb trial in adult lung transplant patients with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in 10% to 20% of infected patients.

22 Feb 2010

Elsevier to celebrate medical education innovation at 60th AMSA convention

Elsevier, the leading publisher of scientific, technical and medical information, today announced it is celebrating medical education innovation at the American Medical Student Association's 60th Annual Convention, March 11-14, 2010, at the Disneyland Hotel in Anaheim, California.

22 Feb 2010

Researchers use new technology to reveal different genetic patterns of neuroblastoma

Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden and Karolinska Institutet have used novel technology to reveal the different genetic patterns of neuroblastoma, an aggressive form of childhood cancer. This discovery may lead to significant advances in the treatment of this malignant disease, which mainly affects small children.

22 Feb 2010

Prediction of sport injuries through equations

Spanish researchers have developed a new mathematical model that permits to predict sport injuries from a series of equations. Their work has proved that sport injuries that affect the lower limbs in high-impact sport, such as football, athletics or basketball, can be predicted through the use of equations of logistic regression.

22 Feb 2010

ResMed launches S9 sleep apnoea therapy platform in Europe

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes.

From ResMed Corp 22 Feb 2010

Researchers use new techniques to investigate the nature violence

Douglas J. Wiebe, PhD, assistant professor of Epidemiology at the University of Pennsylvania School of Medicine will present portions of an ongoing study about the daily activities of youth and their risk of being violently injured.

22 Feb 2010

Smokers, tobacco users and high alcohol consumers: Get mouths, gums and tongues checked for cancer

The National Basketball Association's (NBA) Denver Nuggets Coach George Karl announced today that he has been diagnosed with treatable neck and throat cancer. According to published media reports, Karl's physician says the coach has cancer of his right tonsil that has spread to a lymph node in his neck. The 58-year-old Karl, who is also a prostate cancer survivor, coached in the NBA's All-Star game this past weekend.

22 Feb 2010

Choking among children: AAP releases new policy statement

Choking is a leading cause of injury and death among children, especially those younger than 4 years of age. The majority of choking-related incidents among children are associated with food, coins and toys. A new policy statement from the American Academy of Pediatrics (AAP), led by a doctor at Nationwide Children's Hospital and published in the February 22 online issue of Pediatrics, takes a closer look at preventing choking among children.

22 Feb 2010

Researchers identify common gene variant associated with atrial fibrillation

An international research team has identified a common gene variant associated with a form of the irregular heartbeat called atrial fibrillation. In their report in the journal Nature Genetics, being published online, the investigators describe finding that variations affecting a protein that may help control the heart's electrical activity appear to increase the risk of what is called lone atrial fibrillation (AF), a type seen in younger individuals with no other form of heart disease.

22 Feb 2010

Four key elements essential for transforming health care delivery to be discussed at stakeholder's meeting

As the patient centered medical home moves onto the front burner as a model for transforming health care delivery, thought leaders are focusing on four key elements essential to making the model successful. These elements—care coordination, expanded access, meaningful health IT and new financial models—will be the foundation for the Patient-Centered Primary Care Collaborative's March 30 Stakeholder's Meeting in Washington, DC at the Ronald Reagan International Trade Center.

22 Feb 2010

Cancer pain patients: European regulations restricting access to opioid-based drugs

Many cancer patients in Europe are being denied access to adequate pain relief because of over-zealous regulations restricting the availability and accessibility of opioid-based drugs such as morphine.

22 Feb 2010

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

For nearly half a century, scientists have been trying to figure out how to build a cost-effective and reasonably sized X-ray laser that could, among other things, provide super high-resolution imaging. And for the past two decades, University of Colorado at Boulder physics professors Margaret Murnane and Henry Kapteyn have been inching closer to that goal.

22 Feb 2010

Study proposes potential molecular mechanism at play in mild TBI

Douglas Smith, MD, director of the Center for Brain Injury and Repair and professor of Neurosurgery at the University of Pennsylvania School of Medicine, will present information on the molecular mechanism at play in mild TBI (mTBI), commonly called concussions. Although mTBI affects over 1 million people each year in the United States, it is generally ignored as a major health issue. However, this 'mild' form of injury induces persisting neurological and cognitive problems in many of these patients, exacting an enormous emotional and financial toll on society.

22 Feb 2010

Medicine News and Research

Study shows hospitals costs vary widely and are not associated with quality of care

Cancer Institute awards MCRA designation to Cooper University Hospital

Senate, FDA reports increasing concerns about controversial diabetes drug

DSAEK cornea transplant offers potential long-term benefits

Gilead Sciences receives FDA approval for new inhaled antibiotic in treatment of CF

U.S. HealthWorks expands its footprint in Arizona by acquiring three healthcare centers

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Elsevier to celebrate medical education innovation at 60th AMSA convention

Researchers use new technology to reveal different genetic patterns of neuroblastoma

Prediction of sport injuries through equations

ResMed launches S9 sleep apnoea therapy platform in Europe

Researchers use new techniques to investigate the nature violence

Smokers, tobacco users and high alcohol consumers: Get mouths, gums and tongues checked for cancer

Choking among children: AAP releases new policy statement

Researchers identify common gene variant associated with atrial fibrillation

Four key elements essential for transforming health care delivery to be discussed at stakeholder's meeting

Cancer pain patients: European regulations restricting access to opioid-based drugs

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

Study proposes potential molecular mechanism at play in mild TBI

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News